Advanced follicular lymphoma study using your lab samples
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at advanced follicular lymphoma by analyzing samples of blood and tissue (and sometimes bone marrow) you may have already provided. It may help doctors understand your lymphoma better and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be enrolled in the FIL_FOLL12 trial and have signed the study consent
- You must have biological samples available to test
- The study needs a bone marrow sample (bone marrow aspirate)
- The study needs a blood sample (peripheral blood) and/or a tissue sample saved for testing (FFPE)
- Your saved tissue can be from a lymph node or other body area (nodal or extranodal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and tumor tissue samples from people newly diagnosed with aggressive non-Hodgkin lymphoma who will receive standard chemotherapy. The goal is to improve future tests for detecting minimal residual disease (tiny amounts of cancer left after treatment).
This study asks people with follicular lymphoma to share their experiences during treatment. It's not testing a new drug—it's collecting information to help improve care.
This trial checks whether a blood test that looks for small amounts of cancer DNA can accurately track minimal residual disease (MRD) in lymphoma patients during CAR-T therapy. It may help doctors detect relapse earlier and better judge how well CAR-T is working.
This study looks at how follicular lymphoma cells change (“clonal evolution”) over time. It may help doctors understand disease behavior and guide better future treatments, especially when people may need treatment soon.
This trial looks at your tumor’s genetic information from stored tissue to help match you to early-phase treatment options. It may help doctors find a therapy that fits your tumor, especially when standard options have limited benefit.
This study collects blood and tissue samples from people with B-cell non-Hodgkin lymphoma who are receiving new antibody treatments. The samples help researchers understand how well these treatments work and why they might help some people more than others.
Hear when a new Follicular Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.